IVF Hartmann Holding AG (VBSN.SW) has a MoatMap StockRank of 96/100 based on Quality (80/100), Value (61/100), and Momentum (47/100) factor scores. The current signal is STRONG BUY. IVF Hartmann is a stable Swiss medical products company, but it lacks the high-growth reinvestment runway and the powerful macro tailwinds required for a concentrated global equity portfolio.
IVF Hartmann Holding AG designs, manufactures, and distributes medical consumables, including wound care, infection prevention, and incontinence management products, primarily for the Swiss healthcare market. The company possesses a strong competitive position backed by its long-standing relationships with Swiss hospitals, pharmacies, and nursing homes, alongside the global distribution network of its parent, the Hartmann Group. It is a leading, trusted supplier of medical instruments and supplies in Switzerland.
| Price | $161.30 |
| Market Cap | $378M |
| P/E (TTM) | 16.25 |
| Price/Book | 1.90 |
| Return on Equity | 11.9% |
| Return on Invested Capital | 13.4% |
| Debt/Equity | 0.48 |
| Gross Margin | 55.5% |
| Operating Margin | 13.6% |
| Revenue Growth | 2.6% |
| Dividend Yield | 3.1% |
| Free Cash Flow | $20M |
IVF Hartmann Holding AG operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (Switzerland).